Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics
PROPOSED NEW MEDICARE RULES by the Office of the Investigator General (OIG) dealing with ādiscriminatory billing practicesā and āusual chargesā should be seen as part of a larger trend. The government doesnāt have the money to pay for Medicare and Medicaid. Thus, it is exploring indirect ways to reduce the amount of money it pays …
CEO SUMMARY: Federal regulators are taking another crack at defining āusual charges.ā Language in the proposed rules published last month precisely defines which payers should be included in determining āusual chargesā and what charge basis to use for specific payers. Once effective, the new rules will have financial impact on many laboratories, particularly those known …
CEO SUMMARY: As new diagnostic technologies move through the development pipeline and into widespread clinical use, the scientific knowledge and skill sets needed by laboratory staff and management will change. The emphasis in laboratory medicine will evolve to include more molecular technology, but this evolution will proceed incrementally, giving all laboratories time to adapt. RAPID …
No Disruptive Technology In Lab Industryās Future Read More »
CEO SUMMARY: This exclusive intelligence briefing predicts how specific new technologies may drive changes in the laboratory-testing marketplace during the next five years. The key message is that change is expected to be incremental, not disruptiveāgiven the technology known to be in development at this time. But the more provocative insight relates to how even …
Looking at Fast-Growth And Slow-Growth Areas In Diagnostic Testing Read More »
GROWTH IN SPECIMEN VOLUME and revenues is the major challenge at the nationās two largest laboratory corporations. How Laboratory Corporation of America and Quest Diagnostics Incorporated solve this problem will affect and influence every remaining clinical laboratory and pathology group practice in the United States. Thatās because the marketing and pricing strategies of the two …
Two Blood Brothers Ramp Up Marketing of New Lab Assays Read More »
Hereās a reminder that corporate fraud didnāt bypass healthcare. Last week Albert Bergonzi, former Executive Vice President of McKesson/HBOC, pled guilty to violations of securities laws. He admitted that he had ācooked the booksā around the time of HBOCās acquisition by McKesson. In a court filing, Borgzoni declared āwe falsely inflated quarterly soft- ware sales …
“October 20, 2003 Intelligence: Late Breaking Lab News” Read More »
The Dark Report ā¢ 21806 Briarcliff Dr ā¢ Spicewood, TX 78669
Phone: 512-264-7103 ā¢ Toll Free Number: 800-560-6363
Email: customerservice@darkintelligencegroup.com
Ā© 2022 The Dark Report. All rights reserved.